608
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Genome-wide association study of co-occurring anxiety in major depression

, , , , , , , , , , , , , , , , , , , , & show all
Pages 611-621 | Received 15 Dec 2011, Accepted 26 Feb 2013, Published online: 19 Sep 2013

References

  • American Psychiatric Association. 2000. Diagnostic and statistical manual of mental disorders (DSM-IV-TR), 4th ed. Text revision. Washington, DC: American Psychiatric Association.
  • Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. 2001. Controlling the false discovery rate in behavior genetics research. Behav Brain Res 125:279–284.
  • Biederman J, Petty C, Hirshfeld-Becker DR, Henin A, Faraone SV, Dang D, et al. 2006. A controlled longitudinal 5-year follow-up study of children at high and low risk for panic disorder and major depression. Psychol Med 36:1141–1152.
  • Brunig I, Suter A, Knuesel I, Luscher B, Fritschy JM. 2002. GABAergic terminals are required for postsynaptic clustering of dystrophin but not of GABAA receptors and gephyrin. J Neurosci 22:4805–8013.
  • Chelly J, Kaplan JC, Maire P, Gautron S, Kahn A. 1988. Transcription of the dystrophin gene in human muscle and non-muscle tissues. Nature 333:858–860.
  • Devlin B, Roeder K. 1999. Genomic control for association studies. Biometrics 55:997–1004.
  • Dranovsky A, Hen R. 2006. Hippocampal neurogenesis: regulation by stress and antidepressants. Biol Psychiatry 59:1136–1143.
  • Dudbridge F, Gusnanto A. 2008. Estimation of significance thresholds for genomewide association scans. Genet Epidemiol 32:227–234.
  • Duman RS, Monteggia LM. 2006. A neurotrophic model for stress-related mood disorders. Biol Psychiatry 59:1116–1127.
  • Farmer A, Breen G, Brewster S, Craddock N, Gill M, Korszun A, et al. 2004. The Depression Network (DeNT) Study: methodology and sociodemographic characteristics of the first 470 affected sibling pairs from a large multi-site linkage genetic study. BMC Psychiatry 4:42.
  • Fava M, Uebelacker LA, Alpert JE, Nierenberg AA, Pava JA, Rosenbaum JF. 1997. Major depressive subtypes and treatment response. Biol Psychiatry 42:568–576.
  • Fava M, Rosenbaum JF, Hoog SL, Tepner RG, Kopp JB, Nilsson ME. 2000. Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression. J Affect Disord 59:119–126.
  • Fava M, Rush AJ, Alpert JE, Balasubramani GK, Wisniewski SR, Carmin CN, et al. 2008. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. Am J Psychiatry 165:342–351.
  • Fitzpatrick C, Barry C, Garvey C. 1986. Psychiatric disorder among boys with Duchenne muscular dystrophy. Dev Med Child Neurol 28:589–595.
  • Graf ER, Zhang XZ, Jin SX, Linhoff MW, Craig AM. 2004. Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins. Cell 119:1013–1026.
  • Graves L, Dalvi A, Lucki I, Blendy JA, Abel T. 2002. Behavioral analysis of CREB alphadelta mutation on a B6/129 F1 hybrid background. Hippocampus 12:18–26.
  • Gur TL, Conti AC, Holden J, Bechtholt AJ, Hill TE, Lucki I, et al. 2007. cAMPresponse element-binding protein deficiency allows for increased neurogenesis and a rapid onset of anti depressant response. J Neurosci 27:7860–7868.
  • Hebda-Bauer EK, Watson SJ, Akil H. 2004. CREB deficient mice show inhibition and low activity in novel environments without changes in stress reactivity. Eur J Neurosci 20:503–513.
  • Hettema JM. 2008. What is the genetic relationship between anxiety and depression?Am J Med Genet C Semin Med Genet 148C:140–146.
  • Hettema JM, Prescott CA, Kendler KS. 2001. A population-based twin study of generalized anxiety disorder in men and women. J Nerv Ment Dis 189:413–420.
  • Hirschfeld RM, Klerman GL. 1979. Personality attributes and affective disorders. Am J Psychiatry 136:67–70.
  • Hirschfeld RM, Klerman GL, Lavori P, Keller MB, Griffith P, Coryell W. 1989. The influence of alcoholism on the course of depression. J Affect Disord 16:151–158.
  • Hoffman EP, Brown RHJ, Kunkel LM. 1987. Dystrophin: the protein product of Duchenne muscular dystrophy locus. Cell 51:919–928.
  • Kang Y, Craig AM. 2006. Composition and assembly of GABAergic postsynaptic specializations. In: Dityatev A, El-Husseini A, editors. Molecular mechanisms of synaptogenesis. New York: Springer Science + Business Media LLC. p. 277–295.
  • Kendler KS, Neale MC, Kessler RC, Heath AC, et al. 1993. Panic disorder in women – A population-based twin study. Psychol Med 23:397–406.
  • Kendler KS, Prescott CA, Myers J, Neale MC. 2003. The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Arch Gen Psychiatry 60:929–937.
  • Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. 2005a. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62:593–602.
  • Kessler RC, Chiu WT, Demler O, Walters EE. 2005b. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62:617–627.
  • Knuesel I, Mastrocola M, Zuellig RA, Bornhauser B, Schaub MC, Fritschy JM. 1999. Altered synaptic clustering of GABAA receptors in mice lacking dystrophin (mdx mice). Eur J Neurosci 11:4457–4462.
  • Komoto J, Usui S, Otsuki S, Terao A. 1984. Infantile autism and Duchenne musclular dystrophy. J Autism Dev Disord 14: 191–195.
  • Levi S, Grady RM, Henry MD, Campbell KP, Sanes JR, Craig AM. 2002. Dystroglycan is selectively associated with inhibitory GABAergic synapses but is dispensable for their differentiation. J Neurosci 22:4274–4285.
  • Lewis C, Ng MY, Butler AW, Cohen-Woods S, Uher R, Pirlo K, et al. 2010. Genome-wide association study of major recurrent depression in the UK population. Am J Psychiatry 167: 949–957.
  • Lidov HG, Byers TJ, Watkins SC, Kunkel LM. 1990. Localization of dystrophin to postsynaptic regions of central nervous system cortical neurons. Nature 348:725–728.
  • McGuffin P, Katz R, Aldrich J. 1986. Past and present state examination: the assessment of ‘lifetime ever’ psychopathology. Psychol Med 16:461–465.
  • McGuffin P, Knight J, Breen G, Brewster S, Boyd PR, Craddock N, et al. 2005. Whole genome linkage scan of recurrent depressive disorder from the depression network study. Hum Mol Genet 14:3337–3345.
  • Middeldorp CM, Hottenga JJ, Slagboom PE, Sullivan PF, de Geus EJ, Posthuma D, et al. 2008. Linkage on chromosome 14 in a genome-wide linkage study of a broad anxiety phenotype. Mol Psychiatry 13:84–89.
  • Nakagawa S, Kim JE, Lee R, Chen J, Fujioka T, Malberg J, et al. 2002a. Localization of phosphorylated cAMP response element-binding protein in immature neurons of adult hippocampus. J Neurosci 22:9868–9876.
  • Nakagawa S, Kim JE, Lee R, Malberg JE, Chen J, Steffen C, et al. 2002b. Regulation of neurogenesis in adult mouse hippocampus by cAMP and the cAMP response element-binding protein. J Neurosci 22:3673–3682.
  • Nelson EC, Grant JD, Bucholz KK, Glowinski A, Madden PAF, Reich W, et al. 2000. Social phobia in a population-based female adolescent twin sample: co-morbidity and associated suicide-related symptoms. Psychol Med 30: 797–804.
  • Nelson JC. 2008. Anxious depression and response to treatment. Am J Psychiatry 165:297–299.
  • Nelson JC. 2010. Anxiety does not predict response to duloxetine in major depression: results of a pooled analysis of individual patient data from 11 placebo-controlled trials. Depress Anxiety 27:12–18.
  • Nelson JC, Delucchi K, Schneider LS. 2009. Anxiety does not predict response to antidepressant treatment in late life depression: results of a meta-analysis. Int J Geriatr Psychiatry 24:539–544.
  • Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. 2006. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38:904–909.
  • Purcell S, Cherny SS, Sham PC. 2003. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19:149–150.
  • Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. 2007. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559–575.
  • Russel JM, Koran LM, Rush J, Hirschfeld RM, Harrison W, Friedman ES, et al. 2001. Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression. Depress Anxiety 13:18–27.
  • Schormair B, Kemlink D, Roeske D, Eckstein G, Xiong L, Lichtner P, et al. 2008. PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless leg syndrome. Nat Genet 40:946–948.
  • Schosser A, Gaysina D, Cohen-Woods S, Chow PC, Martucci L, Craddock N, et al. 2010. Association of DISC1 and TSNAX genes and affective disorders in the depression case-control DeCC) and bipolar affective case-control (BACCS) studies. Mol Psychiatry 15:844–849.
  • Sham P, Sterne A, Purcell S, Cherny SS, Webster M, Rijsdijk FV, et al. 2000. GENESiS: creating a composite index of the vulnerability to anxiety and depression in a community-based sample of siblings. Twin Res 3:316–322.
  • Smoller JW, Gardner-Schuster E, Misiaszek M. 2008. Genetics of anxiety: would the genome recognize the DSM?Depress Anxiety 25:368–377.
  • Sullivan PF, Neale MC, Kendler KS. 2000. Genetic epidemiology of major depression: Review and meta-analysis. Am J Psychiatry 157:1552–1562.
  • Uher R, Huezo-Diaz P, Perroud N, Smith R, Reitschel M, Mors O, et al. 2009. Genetic predictors of response to anti depressants in the GENDEP project. Pharmacogenomics J 9:225–233.
  • Uher R, Demovsek MZ, Mors O, Hauser J, Souery D, Zobel A, et al. 2011. Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline. J Affect Disord 132:112–120.
  • Weissman MM, Wickramaratne P, Nomura Y, Warner V, Verdeli H, Pilowsky DJ, et al. 2005Families at high and low risk for depression: a 3-generation study. Arch Gen Psychiatry 62: 29–36.
  • Wing JK, Babor T, Brugha T, Burke J, Cooper JE, Giel R, et al. 1990. SCAN. Schedules for clinical assessment in neuro psychiatry. Arch Gen Psychiatry 47:589–593.
  • Wittchen HU. 2000. Epidemiology of affective disorders. In: Contemporary Psychiatry. Vol 3. Helmchen H, Henn F, Lauter H, Sartorius N, editors. Heidelberg: Springer. p. 231–241.
  • World Health Organisation. 1993. The ICD-10 Classification of mental and behavioural disorders. Diagnostic criteria for research. Geneva: WHO.
  • Zhu K, Xu Y, Liu J, Xu Q, Ye H. 2011. Down syndrome cell adhesion molecule and its functions in neural development. Neurosci Bull 27:45–52.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.